Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | ORMP Oramed Pharmaceuticals Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $4.73 -1.3% | $14.86 -2.5% |
| StockIQ Score | 57C Moderate Risk: Medium | 36F Weak Risk: Medium |
| Technical | 56C | 13F |
| Fundamental | 58C | 35F |
| Growth | 60C+ | 50C- |
| Fair Value | 43D | 38F |
| News | 92A+ | 50C- |
| Quality | 42D | 50C- |
| Risk | 48D+ | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Oramed Pharmaceuticals (ORMP) outperforms Ascentage Pharma (AAPG) in nearly every category. Its investor score (60 vs. 37), technical score (73 vs. 18), and fundamental score (58 vs. 35) are significantly stronger, reflecting better market confidence and underlying stability. ORMP also has a moderate rating, while AAPG is rated weak. Only growth (60 vs. 50) and valuation (43 vs. 38) show minor differences.
